Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 311 EP applications David Robert Jaap has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11804061

POSACONAZOLE INTRAVENOUS SOLUTION FORMULATIONS STABILIZED BY SUBSTITUTED BETA-CYCLODEXTRIN

IPC classification:
A61K 31/497, A61K 31/715
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP11815299

INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF

IPC classification:
C12N 7/04, A61K 39/245, A61K 39/25, A61K 39/275, A61K 39/285
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP11865332

RECOMBINANT SUBUNIT DENGUE VIRUS VACCINE

IPC classification:
A61K 39/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11769326

PYRIDONE DERIVATIVES

IPC classification:
C07D 213/69, C07D 401/04, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP11836929

HIV INTEGRASE INHIBITORS

IPC classification:
A61K 31/235, A61K 31/66
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11760037

NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE

IPC classification:
A01N 43/50, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11875249

FUSED HETEROCYCLIC AZAINDANE CARBOXAMIDE CGRP RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP11796211

TETRAHYDROQUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61P 25/00, C07D 215/00, C07D 215/48, C07D 401/06, C07D 401/14, C07D 405/14, C07D 471/04, A61K 31/4725
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP12749051

NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS

IPC classification:
A01N 43/58
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP11816846

POSITIVE ALLOSTERIC MODULATORS OF MGLUR2

IPC classification:
C07D 235/26, C07D 401/04, C07D 401/06, C07D 401/10, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/10, C07D 405/06, C07D 405/10, C07D 409/10, C07D 413/10, C07D 417/14, C07D 453/02, C07D 471/04, C07D 513/14, A01N 43/50, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP12767839

C5-C6 OXACYCLIC-FUSED THIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 285/00, A61K 31/54
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12771100

5-SUBSTITUTED IMINOTHIAZINES AND THEIR MONO-AND DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61P 25/16, A61P 25/28, C07D 279/12, C07D 417/04, C07D 417/12, C07D 417/14, A61K 31/54, A61K 31/541
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11787178

NAPHTHALENE CARBOXAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61P 25/04, A61P 25/20, A61P 25/28, A61K 31/16
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP11839952

ENOLASE PEPTIDE CONJUGATE VACCINES AGAINST STAPHYLOCOCCUS AUREUS

IPC classification:
C07K 7/00, C07K 14/31, C12N 9/88, A61K 38/00, A61K 39/00, A61K 39/085
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12725988

CB-183,315 COMPOSITIONS AND RELATED METHODS

IPC classification:
A61K 9/14, A61K 9/20
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11815098

FUSED-IMIDAZOYL COMPOUNDS USEFUL AS ANTIMICROBIAL AGENTS

IPC classification:
A61P 31/04, A61P 31/10, C07D 471/04, C07D 487/04, A61K 31/497, A61K 31/4985
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11833017

FUSED TETRACYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61P 31/12, A01N 43/64, A01N 43/42, A01N 43/58, A01N 43/90
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP11833019

POLYCYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61P 31/12, A61K 31/404, A61K 31/4178, A61K 31/423, A61K 31/517, A61K 31/519, A61K 31/555, A61K 31/675, A61K 31/7056, A61K 38/00, A61K 38/12, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12801916

IMMOBILIZED TRANSAMINASES AND PROCESS FOR MAKING AND USING IMMOBILIZED TRANSAMINASE

IPC classification:
C07K 14/00, C12Q 1/52
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12803996

NOVEL CRYSTALLINE FORMS OF A DIPEPTIDYL PEPTIDASE-IV INHIBITOR

IPC classification:
A61K 31/4439, A61K 31/4985, A61K 31/513
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13163216

Heterocyclic aspartyl protease inhibitors

IPC classification:
A61P 25/28, C07D 239/20, C07D 401/04, C07D 401/10, C07D 403/04, C07D 405/04, C07D 409/14, C07D 411/04, C07D 417/04, C07D 417/14, C07D 495/20, A61K 31/513
Applicant:
Merck & Co. Inc.
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP12814549

BTK INHIBITORS

IPC classification:
A61P 3/10, A61P 7/02, A61P 9/00, A61P 19/02, A61P 25/00, C07D 497/02, A61K 31/437, A61K 31/4985, A61K 31/519, A61K 31/52, A61K 31/53
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12825781

2-SPIRO-SUBSTITUTED IMINOTHIAZINES AND THEIR MONO-AND DIOXIDES AS BACE INHIBITORS, COMPOSITIONS AND THEIR USE

IPC classification:
A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12830590

TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61P 31/14, C07D 307/82, C07D 405/10, A61K 31/343
Applicant:
Merck & Co. Inc.
Applicant:
MSD Italia S.r.l.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12829739

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61P 31/12, A61P 31/14, C07D 307/82, C07D 307/83, C07D 405/04, C07D 405/14, A61K 31/343
Applicant:
Merck & Co. Inc.
Applicant:
MSD Italia S.r.l.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12829730

HETEROCYCLIC-SUBSTITUED BENZOFURAN DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61P 31/14, C07D 405/14, C07D 413/14, A61K 31/343
Applicant:
Merck & Co. Inc.
Applicant:
MSD Italia S.r.l.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12832311

SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07F 7/10
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12831707

SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07F 7/10
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12766769

COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61P 31/00, C07H 19/20, A61K 31/7076
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
Jones Day
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12831151

COMPOSITIONS AND METHODS FOR TREATING CANCER

IPC classification:
A01N 43/54
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12834277

PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS

IPC classification:
A61P 11/00, A61P 29/00, A61P 35/00, C07D 401/04, C07D 401/14, C07D 405/04, C07D 405/14, C07D 409/04, C07D 409/14, C07D 413/14, C07D 417/14, A61K 31/4155, A61K 31/4439, A61K 31/541
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12833964

SUBSTITUTED PYRIMIDINES

IPC classification:
A01N 43/54, A61K 31/4965, A61K 31/50
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12833410

CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS

IPC classification:
A61P 35/00, A61P 37/00, C07D 231/10, A61K 31/415
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12834358

ACYCLIC CYANOETHYLPYRAZOLES AS JANUS KINASE INHIBITORS

IPC classification:
C07D 231/02, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12834521

SUBSTITUTED PYRIMIDINES

IPC classification:
A01N 43/54, A61K 31/4965, A61K 31/50
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12834379

CYANOMETHYLPYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS

IPC classification:
C07D 231/02, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13180590

Combination drugs comprising aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes

IPC classification:
A61P 3/10, C07D 487/04, A61K 9/00, A61K 9/20, A61K 31/4162
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13180593

Combination drugs comprising aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes

IPC classification:
A61P 3/10, C07D 487/04, A61K 9/20, A61K 31/4162
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13180592

Combination drugs comprising aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes

IPC classification:
A61P 3/10, C07D 487/04, A61K 9/20, A61K 31/4162
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12838515

AZAINDOLES AS JANUS KINASE INHIBITORS

IPC classification:
A01N 43/62
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12838571

3-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS

IPC classification:
C07D 401/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12838160

PHENYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS

IPC classification:
C07D 401/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12776679

PROCESS FOR THE PREPARATION OF AN OREXIN RECEPTOR ANTAGONIST

IPC classification:
C07D 249/06, C07D 413/04, C07D 413/14, A01N 43/62, A61K 31/55
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12780370

2-PYRIDYLOXY-4-NITRILE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61P 25/00, A61P 25/20, C07D 401/14, C07D 409/14, C07D 413/14, C07D 417/14, A61K 31/4545
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12780359

SUBSTITUTED 3',5'-CYCLIC PHOSPHATES OF PURINE NUCLEOTIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61P 31/12, C07H 19/213, A61K 31/7076
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
Anton Hutter, Venner Shipley LLP
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP12844551

PROCESS FOR MAKING BETA 3 AGONISTS AND INTERMEDIATES

IPC classification:
A61K 31/427
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12843729

HIV PROTEASE INHIBITORS

IPC classification:
A61P 31/18, C07D 277/28, C07D 333/20, C07D 409/12, C07D 413/12, C07D 417/12, C07D 417/14, C07D 471/04, C07D 487/04, A61K 31/33, A61K 31/381, A61K 31/404, A61K 31/42, A61K 31/4245, A61K 31/428, A61K 31/4365, A61K 31/437, A61K 31/4439, A61K 31/4725, A61K 31/4985
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12842776

PROCESS FOR MAKING BETA 3 ANGONISTS AND INTERMEDIATES

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12845873

AMINOPYRIMIDINONES AS INTERLEUKIN RECEPTOR-ASSOCIATED KINASE INHIBITORS

IPC classification:
A01N 43/54
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12846336

COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/4035
Applicant:
Merck & Co. Inc.
Applicant:
MSD Italia S.r.l.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12846357

NANO-SUSPENSION PROCESS

IPC classification:
A61K 9/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12758300

INDOLE DERIVATIVES USEFUL AS CCR2 ANTAGONISTS

IPC classification:
A61P 19/02, C07D 403/12, C07D 491/04, A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12757995

SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVES USEFUL AS CCR2 ANTAGONISTS

IPC classification:
C07D 209/52, C07D 401/08, C07D 403/06, C07D 403/08, C07D 405/04, C07D 405/08, C07D 409/08, C07D 413/04, C07D 417/04, C07D 417/08, C07D 471/04, C07D 493/14, A01N 43/64, A61K 31/41
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11807331

PROTECTIVE VACCINE BASED ON STAPHYLOCOCCUS AUREUS PROTEIN SA2412

IPC classification:
A61K 39/085
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11783995

SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS

IPC classification:
A61P 3/00, A61P 3/04, A61P 3/06, A61P 3/10, A61P 25/22, A61P 25/24, C07D 498/10, C07D 519/00, A61K 31/438
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11812998

INHIBITION OF CYP3A DRUG METABOLISM

IPC classification:
A01N 37/18, A61K 38/07, A61K 38/21
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12846579

QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP11775453

PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
C07D 401/14, A01N 43/46, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11792924

NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
C07D 401/14, A61K 31/454, A61K 31/4545, A61K 31/5377, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11792941

NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
C07D 401/14, C07D 413/14, C07D 417/04, C07D 417/14, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP13188869

Method of treatment using fatty acid synthesis inhibitors

IPC classification:
A61P 3/04, A01N 43/04, A61K 31/195, A61K 31/70
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12851733

METHOD FOR PREPARATION OF ALUMINUM HYDROXYPHOSPHATE ADJUVANT

IPC classification:
A61K 39/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12771566

2'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07H 19/06, C07H 19/10, C07H 19/11, C07H 19/12, C07H 19/16, C07H 19/20, C07H 19/207, C07H 19/213, C07H 21/02, A61K 31/7042, A61K 31/7068, A61K 31/7072, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12771707

2'-AZIDO SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07H 19/06, C07H 19/10, C07H 19/11, C07H 19/12, C07H 19/16, C07H 19/20, C07H 19/207, C07H 19/213, C07H 21/02
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12850024

TRIAZOLOPYRIDINONE PDE10 INHIBITORS

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12800460

METHODS OF PURIFICATION OF NATIVE OR MUTANT FORMS OF DIPHTHERIA TOXIN

IPC classification:
C07H 21/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12855868

PYRROLOPYRIMIDINES AS JANUS KINASE INHIBITORS

IPC classification:
C07D 487/02, C07D 487/04, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12767881

SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

IPC classification:
A61P 5/50, C07D 211/22, C07D 401/12, C07D 405/04, C07D 413/04, C07D 413/14, C07D 417/14, C07D 471/04, C07D 487/04, C07D 495/04, C07D 498/04, C07D 513/04, A61K 31/506
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12710633

TRICYCLIC GYRASE INHIBITORS

IPC classification:
A61P 31/04, C07D 487/04, C07D 487/14, A61K 31/495
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Lawrence Livermore National Security, LLC
Agent:
Multiple attorneys, F. R. Kelly & Co.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12860596

SUBSTITUTED PIPERIDINES AS HDM2 INHIBITORS

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12735138

4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AND 4-IMIDAZOTRIAZIN-1-YL-BENZAMIDES BTK-INHIBITORS

IPC classification:
A61P 19/08, A61P 29/00, A61P 31/00, A61P 35/00, A61P 37/00, C07D 487/04, C07D 519/00, A61K 31/4985
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12733505

4 - IMIDAZOPYRIDAZIN- 1 -YL-BENZAMIDES AND 4 - IMIDAZOTRIAZIN- 1 - YL - BENZAMIDES AS BTK- INHIBITORS

IPC classification:
A61P 19/08, A61P 29/00, A61P 31/00, A61P 35/00, A61P 37/00, C07D 487/04, C07D 519/00, A61K 31/4985
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12786166

N-LINKED QUINOLINEAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61P 25/28, C07D 401/06, C07D 401/14, C07D 403/12, C07D 405/14, A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11816747

STAPHYLOCOCCUS AUREUS SURFACE PROTEIN SA1789 AND PROTECTIVE VACCINE BASED THEREON

IPC classification:
C07K 14/195, A61K 39/00, A61K 39/085, A61K 39/38
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12800485

SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF TREATMENT

IPC classification:
C07D 211/22, C07D 211/24, C07D 401/04, C07D 401/14, C07D 405/14, C07D 413/04, C07D 413/14, C07D 417/14, A01N 43/40, A61K 31/445
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12779558

PROCESSES FOR PREPARING INHIBITORS OF THE HEPATITIS C VIRUS

IPC classification:
C07D 209/52, A01N 43/90
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12773555

TASTE-MASKED FORMULATIONS OF RALTEGRAVIR

IPC classification:
A01N 43/82, A61K 9/00, A61K 9/16, A61K 9/20, A61K 9/50, A61K 31/41, A61K 31/513, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12801127

IMIDAZOPYRIDIN-2-ONE DERIVATIVES

IPC classification:
C07D 471/04, C07D 513/04, C07D 519/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP14185954

Piperidinone carboxamide azaindane CGRP receptor antagonists

IPC classification:
A61P 9/08, C07D 471/10, A61K 31/437, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12799914

CYCLOALKYL-FUSED TETRAHYDROQUINOLINES AS CRTH2 RECEPTOR MODULATORS

IPC classification:
C07D 215/00, C07D 221/16, C07D 401/04, C07D 401/06, C07D 401/10, C07D 401/12, C07D 405/06, C07D 405/12, C07D 409/12, C07D 413/04, C07D 413/12, C07D 417/10, C07D 417/12, A01N 43/42, A61K 31/473, A61K 31/501, A61K 31/506, A61K 31/5377
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13709101

COMBINED SYNTHESIS ROUTE FOR ETONOGESTREL AND DESOGESTREL

IPC classification:
C07J 5/00, C07J 33/00
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13761100

BIS-QUARTERNARY CINCHONA ALKALOID SALTS AS ASYMMETRIC PHASE TRANSFER CATALYSTS

IPC classification:
C07D 453/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13768805

IMIDAZOLYL METHYL PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS

IPC classification:
C07D 471/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12779536

DRUG SUBSTANCES, PHARMECEUTICAL COMPOSITIONS AND METHODS FOR PREPARING THE SAME

IPC classification:
C07D 209/52, A01N 43/90
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP12838717

2-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS

IPC classification:
A61P 37/00, C07D 401/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12838133

1,3-SUBSTITUTED AZETIDINE PDE10 INHIBITORS

IPC classification:
A61P 25/18, A61P 25/22, C07D 401/14, C07D 403/14, C07D 405/14, C07D 413/14, C07D 417/14, A61K 31/506
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11827912

TETRACYCLIC INDOLE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION

IPC classification:
A61P 31/12, A61P 31/14, C07D 471/04, C07D 487/04, C07D 498/04, A61K 31/437, A61K 31/4985, A61K 31/5365
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13788440

PYRIDINE CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13787989

PERMEABLE GLYCOSIDASE INHIBITORS AND USES THEREOF

IPC classification:
C07D 513/04
Applicant:
Merck & Co. Inc.
Applicant:
Alectos Therapeutics Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13788254

SPIROLACTAM CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4523
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
The patent has been granted
EP13787557

PROCESS FOR MAKING CGRP RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/90, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13727740

3',5'-CYCLIC PHOSPHORAMIDATE PRODRUGS FOR HCV INFECTION

IPC classification:
A61P 1/16, C07H 19/11
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
Anton Hutter, Venner Shipley LLP
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP13806343

SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS

IPC classification:
A61P 35/00, A61K 31/505
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
The patent has been granted
EP13807108

IMIDAZOLYL ANALOGS AS SYK INHIBITORS

IPC classification:
A61K 31/50, A61K 31/501
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13807050

SUBSTITUTED PYRIDINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS

IPC classification:
A61P 35/00, A61K 31/505
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13730912

METHOD OF TREATING LYMPHOMA USING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61P 35/00, A61K 31/5517
Agent:
Stephan Held, Meissner Bolte & Partnerschaft mbB
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP11784010

NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
A61P 3/04, A61P 3/10, C07D 401/14, C07D 413/14, A61K 31/506
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13807800

PYRAZOLYL DERIVATIVES AS SYK INHIBITORS

IPC classification:
A61K 31/50, A61K 31/501
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13817154

MACROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS

IPC classification:
A01N 43/54, A01N 45/00, A61K 31/70
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13735516

SULFONAMIDE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG

IPC classification:
A61P 31/18, C07D 401/14, C07D 403/14, C07D 417/14, C07D 471/04, C07D 471/10, C07D 487/04, C07D 498/04, A61K 31/454, A61K 31/496, A61K 31/4985
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13819609

HIV TREATMENT WITH AMIDO-SUBSTITUTED PYRIMIDINONE DERIVATIVES

IPC classification:
A61P 31/18, C07D 413/12, A61K 31/506
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13823437

SUBSTITUTED NAPHTHYRIDINEDIONE DERIVATIVES AS HIV INTEGRASE INHIBITORS

IPC classification:
A61P 31/18, C07D 471/04, A61K 31/4375
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP11828123

TETRACYCLIC HETEROCYCLE COMPOUNDS FOR TREATING HEPATITIS C VIRAL INFECTION

IPC classification:
A61P 31/14, C07D 471/04, C07D 471/22, C07D 487/04, C07D 491/22, C07D 493/22, C07D 498/04, A61K 31/437, A61K 31/4985, A61K 31/5365
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13825992

alpha7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF-I

IPC classification:
C07C 311/08, C07C 311/37, C07C 311/48, C07C 311/49, C07D 213/74, C07D 231/38, C07D 237/20, C07D 239/42, C07D 239/47, C07D 241/20, C07D 261/14, C07D 277/42, A61K 31/18, A61K 31/415
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP13760199

METHODS OF ADMINISTERING A 5,5-FUSED HETEROARYLENE HEPATITIS C VIRUS INHIBITOR FOR TREATING OF PREVENTING HEPATITIS C VIRUS INFECTION

IPC classification:
A61P 1/16, A61P 31/14, A61K 31/4184
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
Jones Day
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP14199792

Ceftolozane antibiotic compositions

IPC classification:
A61P 31/00, A61P 31/04, A61K 9/00, A61K 9/19, A61K 31/431, A61K 31/546, A61K 47/02, A61K 47/12, A61K 47/18
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Carpmaels & Ransford LLP
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP13763164

HIV PROTEASE INHIBITORS

IPC classification:
A61P 31/18, C07D 265/30, C07D 265/32, C07D 413/06, C07D 413/12, C07D 413/14, A61K 31/5377
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13765905

TRICYCLIC GYRASE INHIBITORS FOR USE AS ANTIBACTERIAL AGENTS

IPC classification:
C07D 487/04, C07D 487/16, C07D 487/22, C07D 498/22, C07D 515/22
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Lawrence Livermore National Security, LLC
Agent:
Hans-Lothar Arth, ABK Patent, Trademark and Design Attorneys
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP13841687

NOVEL COMPOUNDS THAT ARE ERK INHIBITORS

IPC classification:
A61K 9/66, A61K 31/00, A61K 31/4545
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13840379

CRYSTALLINE FORM OF A REVERSE TRANSCRIPTASE INHIBITOR

IPC classification:
A61K 31/4439
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13773568

ESTERS AND MALONATES OF SATE PRODRUGS

IPC classification:
A61P 31/14, C07H 19/16, A61K 31/7076
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP13776702

5-PHENOXY-3H-PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE AS HIV REVERSE TRANSCRIPTASE INHIBITORS

IPC classification:
A61P 31/18, C07D 239/52, C07D 239/54, C07D 239/56, C07D 401/14, C07D 403/06, C07D 403/14, C07D 471/04, A61K 31/513
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
The patent has been granted
EP13845052

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
C07D 231/02, A61K 31/415, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP13845875

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/44, A61K 31/505
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP11760027

NOVEL SPIRO IMIDAZOLONE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE

IPC classification:
A61P 3/04, A61P 3/10, C07D 401/04, C07D 401/14, C07D 403/12, C07D 403/14, C07D 413/04, C07D 413/14, C07D 491/08, C07D 498/08, A61K 31/4184
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13849733

N-SUBSTITUTED INDAZOLE SULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

IPC classification:
A61K 31/416
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP13854994

PROCESS FOR MAKING AGGLOMERATES USING ACOUSTIC MIXING TECHNOLOGY

IPC classification:
A61K 9/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP13854671

CYCLOBUTYL BENZIMIDAZOLES AS PDE10 INHIBITORS

IPC classification:
A61K 31/4184
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13855525

CYCLOPROPYL IMIDAZOPYRIDINE PDE10 INHIBITORS

IPC classification:
A61K 31/4188
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP13854794

2 -ALKYNYL SUBSTITUTED NUCLEOSIDE DERIVATIVES FOR TREATING VIRAL DISEASES

IPC classification:
C07H 19/02, C07H 19/10, A61K 31/7068
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP13855567

SECONDARY ALCOHOL SUBSITUTED TRIAZOLES AS PDE10 INHIBITORS

IPC classification:
A61K 31/4184
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
The patent has been granted
EP13795957

D-ALANINE ESTER OF RP-NUCLEOSIDE ANALOG

IPC classification:
A61P 31/14, C07H 19/16, A61K 31/7072
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
Anton Hutter, Venner Shipley LLP
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP11827256

HCV NS3 PROTEASE INHIBITORS

IPC classification:
A01N 43/36, A61K 31/40
Applicant:
Merck & Co. Inc.
Applicant:
MSD Italia S.r.l.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13856512

SUBSTITUTED PYRIDONE DERIVATIVES AS PDE10 INHIBITORS

IPC classification:
A61K 31/444
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP15157348

PHARMACEUTICAL COMPOSITION COMPRISING A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR

IPC classification:
A61P 31/18, C07D 401/06, A61K 31/4439
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13858495

COMPOSITIONS AND METHODS FOR TREATING CANCER

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP13860461

DISULFIDE MASKED PRODRUG COMPOSITIONS AND METHODS

IPC classification:
C07D 339/08
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13859616

NUCLEOSIDE KINASE BYPASS COMPOSITIONS AND METHODS

IPC classification:
C07D 339/08
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13860923

BIOCATALYTIC TRANSAMINATION PROCESS

IPC classification:
C07D 211/02
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP13861391

REGIOSELECTIVE N-2 ARYLATION OF INDAZOLES

IPC classification:
A61K 31/454
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP13860921

PROCESS FOR MAKING REVERSE TRANSCRIPTASE INHIBITORS

IPC classification:
A61K 31/4439
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
GRANT OF PATENT INTENDED
EP13862850

BACE INHIBITORS OF IMINOTHIADIAZINE DIOXIDES

IPC classification:
A61P 25/28, C07D 285/18, A61K 31/549
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13864799

4-PYRIDINONETRIAZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS

IPC classification:
C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13818899

SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS

IPC classification:
A61P 35/00, C07D 471/04, C07D 519/00, A61K 31/437, A61K 31/498, A61K 31/5377, A61K 31/538, A61K 31/5383, A61K 31/541, A61K 31/553
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP13865426

GASTRO-RETENTIVE FORMULATIONS

IPC classification:
A61K 9/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13864070

C5-SPIRO IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS

IPC classification:
A61K 31/497, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13865620

C5, C6 OXACYCLIC-FUSED IMINOTHIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS

IPC classification:
C07D 279/12, A61K 31/54
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13864272

C6-AZASPIRO IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS

IPC classification:
C07D 285/00, A01N 43/836, A61K 31/54, A61K 31/549
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13795959

D-ALANINE ESTER OF SP-NUCLEOSIDE ANALOG

IPC classification:
A61P 31/14, C07H 19/16, A61K 31/7072
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13867977

PIPERAZINE-SUBSTITUTED [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

IPC classification:
A61K 31/4985, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
The patent has been granted
EP15167719

INTRAUTERINE DEPOSIT

IPC classification:
A61F 6/14, A61K 9/00
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP15166422

METHOD OF TREATMENT USING FATTY ACID SYNTHESIS INHIBITORS

IPC classification:
A61P 3/04, A01N 43/04, A61K 31/195, A61K 31/70
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13866588

HETEROBICYCLO-SUBSTITUTED-[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

IPC classification:
A61P 25/16, C07D 487/04, A61K 31/4985, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14741091

INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL

IPC classification:
C07D 473/08
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13872073

THIOPHENE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

IPC classification:
A61P 31/14, C07D 409/14, C07D 498/04, A61K 31/5365
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP13871363

HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

IPC classification:
A61P 31/14, C07D 409/14, C07D 498/04, A61K 31/5365
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14743190

BTK INHIBITORS

IPC classification:
C07D 213/75
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14743619

BTK INHIBITORS

IPC classification:
C07D 253/06, C07D 487/04, C07D 519/00, A61K 31/519, A61K 31/52
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14745870

2,6,7,8 SUBSTITUTED PURINES AS HDM2 INHIBITORS

IPC classification:
C07D 473/34
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14749379

2,6,7 SUBSTITUTED PURINES AS HDM2 INHIBITORS

IPC classification:
C07D 413/00, A01N 43/90, A61K 31/52, A61K 31/535
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP11835398

HIV PROTEASE INHIBITORS

IPC classification:
A61P 31/18, C07C 311/29, C07C 311/41, C07D 277/62, C07D 413/12, C07D 417/12, A61K 31/27, A61K 31/428
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP14760677

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14761162

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
The patent has been granted
EP14761134

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
The patent has been granted
EP14760553

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
The patent has been granted
EP15177391

THERAPEUTIC COMPOSITIONS

IPC classification:
A61P 31/04, A61K 9/16, A61K 9/48, A61K 31/545
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14770245

S-IMINO-S-OXO IMINOTHIADIAZINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 285/00, A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14770391

S-IMINO-S-OXO IMINOTHIAZINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14768510

SUBSTITUTED PYRIDIZINONE DERIVATIVES AS PDE10 INHIBITORS

IPC classification:
C07D 237/02, A61K 31/501
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14767603

C2-AZASPIRO IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS

IPC classification:
A61P 25/28, C07D 417/04, A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP11846964

NOVEL FORMULATIONS WHICH MITIGATE AGITATION-INDUCED AGGREGATION OF IMMUNOGENIC COMPOSITIONS

IPC classification:
A01N 25/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP14726464

2',4'-FLUORO NUCLEOSIDES FOR THE TREATMENT OF HCV

IPC classification:
A61P 31/14, C07H 19/06, C07H 19/10, C07H 19/16, C07H 19/20, A61K 31/7072, A61K 31/7076
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14787452

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF - III

IPC classification:
A61P 25/28, A61P 29/00, C07D 401/12, C07D 401/14, C07D 403/12, A61K 31/4427, A61K 31/506
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14798188

FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS

IPC classification:
A61P 31/18, C07D 471/16, C07D 487/16, C07D 491/16, A61K 31/5025, A61K 31/5365
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
The patent has been granted
EP14725702

SLC2A TRANSPORTER INHIBITORS

IPC classification:
A61P 3/00, A61P 25/00, A61P 29/00, A61P 35/00, A61P 37/00, C07D 471/04, C07D 487/04, C07D 519/00, A61K 31/437, A61K 31/4985
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Jeffrey Nicholas Daniels, Page White & Farrer
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14807813

COMPOSITIONS AND METHODS FOR TREATING CANCER

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14811133

FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS

IPC classification:
C07D 265/34
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14814201

CYCLIC PHOSPHONATE SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/66, A61K 31/7105, A61K 31/712
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14816671

HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/343
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14816866

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/343
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP14817438

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP11781053

NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
A61P 3/00, C07D 401/04, C07D 401/14, C07D 413/14, A61K 31/454, A61K 31/4545, A61K 31/506, A61K 31/5377
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11775468

HETEROCYCLIC QUINOLIZINE DERIVED M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61P 25/28, C07D 471/14, A61K 31/47
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14822616

FORMULATIONS FOR CATHEPSIN K INHIBITORS WITH VITAMIN D

IPC classification:
C07C 255/46, A61K 31/277
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14823386

SUBSTITUTED AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES (IRAK-4)

IPC classification:
C07D 487/04, A61K 31/497, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP11835401

SULFONAMIDES AS HIV PROTEASE INHIBITORS

IPC classification:
A61P 31/18, C07C 311/29, C07C 311/41, C07C 317/40, C07C 323/49, C07D 231/12, C07D 261/08, C07D 277/62, C07D 417/12, C07D 417/14, A61K 31/27, A61K 31/415, A61K 31/421, A61K 31/426, A61K 31/427, A61K 31/4439, A61K 31/505, A61K 31/506
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11852164

FUSED HETEROCYCLIC INDANE CARBOXAMIDE AS CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61P 25/06, C07D 471/04, C07D 487/04, A61K 31/015, A61K 31/437, A61K 31/522
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP11745203

SUBSTITUTED AMINOTETRAHYDROTHIOPYRANS AND DERIVATIVES THEREOF AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OF DIABETES

IPC classification:
A61P 3/10, A61K 31/4162, A61K 31/42, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14831878

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 498/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14745163

PHARMACEUTICAL FORMULATION CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61P 35/02, A61K 31/5517
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP14748126

METHOD OF TREATING DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) USING A BET-BROMODOMAIN INHIBITOR

IPC classification:
A61P 35/00, A61K 31/5517
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14833751

OXAZOLE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
C07D 413/04, A61K 31/422, A61K 31/4525, A61K 31/454
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14834750

THIAZOLE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
C07D 413/04, A61K 31/422, A61K 31/4525, A61K 31/454
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP11775458

NOVEL SPIROPIPERIDINE PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
C07D 221/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11783980

NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
C07D 235/02
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15197990

IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07B 59/00, C07D 285/18, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/12, C07D 417/04, C07D 417/12, C07D 417/14, C07D 471/04, C07D 495/04, A61K 31/54
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14838369

7A-HETEROCYCLE SUBSTITUTED- 6, 6-DIFLUORO BICYCLIC HIMBACINE DERIVATIVES

IPC classification:
C07D 405/06, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, MSD UK
Status:
GRANT OF PATENT INTENDED
EP14837408

3'-PYRIDYL SUBSTITUTED- 6,6-DIFLUORO BICYCLIC HIMBACINE DERIVATIVES

IPC classification:
C07D 405/06, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP14837215

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
A01N 43/52, A01N 43/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14837743

7A-AMIDE SUBSTITUTED-6,6-DIFLUORO BICYCLIC HIMBACINE DERIVATIVES

IPC classification:
C07D 405/06, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP14840833

ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN

IPC classification:
A01N 43/40
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14840648

2,2-DIFLUORODIOXOLO A2A RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/58, A01N 43/60
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP11794797

N-SUBSTITUTED AZETIDINE DERIVATIVES

IPC classification:
A61P 5/30, C07D 205/04, C07D 405/12, C07D 409/12, C07D 409/14, C07D 413/12, C07D 417/12, C07D 417/14, A61K 31/397, A61K 31/422, A61K 31/427, A61K 31/433, A61K 31/4439
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11840630

N-Piperidinone-indane carboxamides as CGRP receptor antagonists

IPC classification:
C07D 471/04, C07D 487/04, A61K 31/40, A61K 31/445, A61K 31/506
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP14844214

TRICYCLIC GYRASE INHIBITORS

IPC classification:
A61P 31/04, C07D 487/04, C07D 487/16, C07D 487/22, C07D 515/22, A61K 31/519
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Lawrence Livermore National Security, LLC
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP14844006

C5-SPIRO IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14845934

TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

IPC classification:
A61P 29/00, A61K 31/17, A61K 31/41
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14787071

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61P 31/14, C07D 495/04, A61K 31/4184
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14848447

SOLID FORMS OF CEFTOLOZANE

IPC classification:
A61K 31/431, A61K 31/546, A61K 47/18
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, MSD UK
Status:
GRANT OF PATENT INTENDED
EP14849935

SUBSTITUTED QUINOLIZINE DERIVATIVES USEFUL AS HIV INTEGRASE INHIBITORS

IPC classification:
C07D 455/02, A01N 43/90, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
GRANT OF PATENT INTENDED
EP14847937

FACTOR XIA INHIBITORS

IPC classification:
C07K 14/745
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP14850990

NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS

IPC classification:
A61K 31/435, A61K 31/4439
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14852717

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

IPC classification:
C07D 263/02, C07D 277/02, A61K 31/42, A61K 31/425
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14852979

3,3'-DISUBSTITUTED INDOLINES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN

IPC classification:
C07D 209/02, C07D 209/04, A61K 31/404
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, MSD UK
Status:
GRANT OF PATENT INTENDED
EP14852689

ANTIDIABETIC TRICYCLIC COMPOUNDS

IPC classification:
A61P 3/10, C07D 221/16, C07D 401/12, C07D 401/14, A61K 31/438, A61K 31/444
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, MSD UK
Status:
GRANT OF PATENT INTENDED
EP14851664

FACTOR XIa INHIBITORS

IPC classification:
C07D 413/14, A61K 31/397, A61K 31/7088
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, MSD UK
Status:
GRANT OF PATENT INTENDED
EP14790899

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

IPC classification:
A61P 19/10, C07D 263/34, C07D 413/10, C07D 413/12, C07D 417/10, C07D 417/14, C07D 495/08, C07D 513/08, A61K 31/421, A61K 31/422, A61K 31/427, A61K 31/496, A61K 31/5377, A61K 31/541, A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14853289

METHODS AND INTERMEDIATES FOR PREPARING MACROLACTAMS

IPC classification:
C07B 39/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
GRANT OF PATENT INTENDED
EP14856853

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 405/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14858815

PROCESS FOR PREPARING TETRACYCLIC HETEROCYCLE COMPOUNDS

IPC classification:
C07D 413/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14803272

D-ALANINE PHOSPHORAMIDATE PRONUCLEOTIDES OF 2'-METHYL 2'-FLUORO GUANOSINE NUCLEOSIDE COMPOUNDS FOR THE TREATMENT OF HCV

IPC classification:
A61P 31/12, C07H 19/207, A61K 31/7076, A61K 31/708
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14858933

PSEUDOPOLYMORPHS OF AN HCV NS5A INHIBITOR AND USES THEREOF

IPC classification:
C07D 401/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP11784011

SUBSTITUTED SEVEN-MEMBERED HETEROCYCLIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OF DIABETES

IPC classification:
C07D 471/00, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11847155

TRICYCLIC HETEROCYCLES USEFUL AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS

IPC classification:
A61P 3/10, C07D 487/14, A61K 31/522
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11840448

SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF

IPC classification:
C07D 513/04, C07H 9/06, A61K 31/7056
Applicant:
Merck & Co. Inc.
Applicant:
Alectos Therapeutics Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP14861810

PIPERIDINE OR PIPERAZINE LINKED IMIDAZOLE AND TRIAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG

IPC classification:
A61K 31/4196
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14862098

ANTIDIABETIC TRICYCLIC COMPOUNDS

IPC classification:
C07D 221/16
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14862387

ARYL LINKED IMIDAZOLE AND TRIAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG

IPC classification:
A61K 31/4196
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14861985

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP11747910

BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS

IPC classification:
A61P 3/10, C07D 235/26, C07D 403/04, A61K 31/4184
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14863138

COMPOSITION OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR

IPC classification:
A01N 43/40
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP11818600

SPIROXAZOLIDINONE COMPOUNDS

IPC classification:
A61P 3/00, A61P 9/00, A61P 25/00, C07D 498/10, C07D 519/00, A61K 31/42
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14805555

METHOD OF TREATING LEUKEMIA USING PHARMACEUTICAL FORMULATION CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61P 35/02, A61K 9/10, A61K 9/14, A61K 9/16, A61K 9/48, A61K 31/167, A61K 31/4045, A61K 31/436, A61K 31/519, A61K 31/551, A61K 31/573, A61K 45/06, A61K 47/02, A61K 47/32, A61K 47/38
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14809782

METHOD OF TREATING NON-SMALL-CELL LUNG CANCER USING PHARMACEUTICAL FORMULATION CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61P 35/00, A61K 9/10, A61K 9/14, A61K 9/16, A61K 9/48, A61K 31/436, A61K 31/4545, A61K 31/551, A61K 45/06, A61K 47/02, A61K 47/32, A61K 47/38
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14812112

2'-DICHLORO AND 2'-FLUORO-2'-CHLORO NUCLEOSIDE ANALOGUES FOR HCV INFECTION

IPC classification:
A61P 31/14, C07D 405/04, C07D 473/18, C07D 473/40, C07F 9/6561, C07F 9/6574, C07H 5/02, C07H 11/04, C07H 19/10, C07H 19/11, A61K 31/513, A61K 31/52, A61K 31/522, A61K 31/7064
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14802069

PHARMACEUTICAL FORMULATION COMPRISING LOSARTAN POTASSIUM AND CHLORTHALIDONE

IPC classification:
A61K 9/00, A61K 9/20, A61K 9/46, A61K 31/4178
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14866477

BICYCLOAMINE-SUBSTITUTED-N-BENZENESULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

IPC classification:
C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14868525

ANTIDIABETIC BICYCLIC COMPOUNDS

IPC classification:
A61K 31/075
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14809832

DRUG DELIVERY SYSTEM.

IPC classification:
A61K 9/00, A61K 31/565, A61K 31/569, A61K 47/32
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14870523

SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
C07D 473/00, A61K 31/519, A61K 31/52
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14869616

SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
C07D 473/00, A61K 31/519, A61K 31/52
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14809831

DRUG DELIVERY SYSTEM FOR DELIVERY OF ANTI-VIRALS

IPC classification:
A61K 9/00, A61K 31/5025, A61K 31/506, A61K 47/32
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP14872226

THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
C07D 213/72
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14870755

SPIROCYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS

IPC classification:
C07D 498/04, A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14872398

THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
A61K 31/426
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14871205

ERK INHIBITORS

IPC classification:
A61K 31/437
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14824315

4'-OR NUCLEOSIDES FOR THE TREATMENT OF HCV

IPC classification:
C07H 19/06, C07H 19/16
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14872077

HIV PROTEASE INHIBITORS

IPC classification:
C07D 265/32, C07D 413/12, C07D 413/14
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14872521

HIV PROTEASE INHIBITORS

IPC classification:
A61K 31/5375
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP14871886

IMINOTHIADIAZEPANE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14870683

FUSED TETRACYCLIC HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07D 493/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14872688

THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
C07D 213/72
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14870699

BTK INHIBITORS

IPC classification:
A61P 3/10, A61P 19/02, A61K 31/437
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14872269

BTK INHIBITORS

IPC classification:
A61P 3/10, A61P 19/02, A61K 31/437
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14872471

C-6 SPIROCARBOCYCLIC IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 285/15
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14870903

ANTIDIABETIC SUBSTITUTED HETEROARYL COMPOUNDS

IPC classification:
A61K 31/192, A61K 31/381
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14872578

MEDIA MILLING PROCESS FOR THE MANUFACTURE OF ACTIVE PHARMACEUTICAL INGREDIENTS IN PROPELLANTS

IPC classification:
A61J 3/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14871057

FUSED BICYCLIC ISOXAZOLINES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN

IPC classification:
C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14873215

PYRIMIDONE CARBOXAMIDE COMPOUNDS AS PDE2 INHIBITORS

IPC classification:
A61P 25/18, A61P 25/22, A61P 25/28, C07D 239/36, C07D 401/12, C07D 401/14, C07D 405/12, C07D 405/14, A61K 31/513
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14875049

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 471/10, C07D 487/10
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP15735293

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 405/06, C07D 487/10
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15740935

ISOQUINOLINE DERIVATIVES AS MGAT2 INHIBITORS

IPC classification:
C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP16169994

4-CARBOXYBENZYLAMINO DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS

IPC classification:
A61P 35/00, C07C 237/40, C07D 207/08, A61K 31/17
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15745823

ANTIDIABETIC COMPOUNDS

IPC classification:
C07C 15/14, A61K 31/33, A61K 31/34
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15746725

NOVEL DISINTEGRATION SYSTEMS FOR PHARMACEUTICAL DOSAGE FORMS

IPC classification:
A61K 9/20
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15746174

PHARMACEUTICAL COMPOSITION OF SELECTIVE HCV NS3/4A INHIBITORS

IPC classification:
A61P 31/12, A61K 31/498
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15746768

TABLET FORMULATION FOR CGRP-ACTIVE COMPOUNDS

IPC classification:
C07D 221/02, A61K 9/26, A61K 31/437
Applicant:
Merck & Co. Inc.
Agent:
Hoffmann Eitle PartmbB
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15748475

FACTOR XIA INHIBITORS

IPC classification:
A01N 37/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15748558

FACTOR XIA INHIBITORS

IPC classification:
A01N 37/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP15748498

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

IPC classification:
A01N 43/56
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15746312

ANTIBODIES THAT BIND TO HUMAN TAU AND ASSAY FOR QUANTIFYING HUMAN TAU USING THE ANTIBODIES

IPC classification:
C07K 16/18, A61K 39/395
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15748866

FACTOR XIA INHIBITORS

IPC classification:
A01N 37/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15754598

METHOD FOR TREATING CANCER

IPC classification:
A61P 35/02
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15713053

SOLID FORMS OF A FLAVIVIRIDAE VIRUS INHIBITOR COMPOUND AND SALTS THEREOF

IPC classification:
A61P 31/12, C07D 409/04, A61K 31/4178
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15710076

SOLID PRODRUG FORMS OF 2'-CHLORO-2'-METHYL URIDINE FOR HCV

IPC classification:
A61P 31/14, C07H 19/10, A61K 9/20, A61K 9/48, A61K 31/4184, A61K 31/7072
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15761538

2-PYRAZINE CARBOXAMIDES AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
A61K 31/505, A61K 31/506
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15710533

INDOLE DERIVATIVES FOR USE IN MEDICINE

IPC classification:
A61P 25/00, A61P 31/00, A61P 35/00, A61P 37/00, A61P 43/00, A61K 31/404, A61K 31/4045, A61K 31/405, A61K 31/407, A61K 31/4184, A61K 31/4188, A61K 31/423, A61K 31/424, A61K 31/4355, A61K 31/437
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15780045

SITAGLIPTIN TANNATE COMPLEX

IPC classification:
A61P 3/08, C07D 487/04, A61K 31/4985
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15782608

PHARMACEUTICAL SALTS OF AN OREXIN RECEPTOR ANTAGONIST

IPC classification:
C07D 413/14, A61K 31/423, A61K 31/551
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15786309

METHOD OF TREATING RESISTANT NON-HODGKIN LYMPHOMA, MEDULLOBLASTOMA, AND/OR ALK+NON-SMALL CELL LUNG CANCER USING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61K 31/5517
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15785547

METHOD OF TREATING ACUTE MYELOID LEUKEMIA AND/OR ACUTE LYMPHOBLASTIC LEUKEMIA USING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61K 31/5517
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15723671

METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER USING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61K 31/5517, A61K 45/06
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15795833

ANTIDIABETIC TRICYCLIC COMPOUNDS

IPC classification:
A61P 3/10, C07D 221/16, C07D 401/12, C07D 405/12, A61K 31/415, A61K 31/438
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15800163

METHODS FOR TREATING CANCER WITH A WEE1 INHIBITOR

IPC classification:
A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15803641

C2-CARBOCYCLIC IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 417/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15802906

IMIDAZO-PYRAZINE DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15806506

ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF

IPC classification:
C07C 311/08, C07C 311/37, A61K 31/18
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15730293

METHOD OF TREATING NON-SMALL CELL LUNG CANCER AND/OR SMALL CELL LUNG CANCER USING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61P 35/00, A61K 9/10, A61K 9/14, A61K 9/16, A61K 9/48, A61K 31/436, A61K 31/4545, A61K 31/551, A61K 45/06, A61K 47/02, A61K 47/32, A61K 47/38
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP16198994

PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-NUCLEATING AGENT

IPC classification:
A61K 9/20, A61K 9/48, A61K 31/513
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION PUBLISHED
EP15814626

METHODS AND COMPOSITIONS FOR TREATING DISEASES AND CONDITIONS

IPC classification:
A61K 31/506
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15832439

SYNTHESIS OF CEPHALOSPORIN COMPOUNDS

IPC classification:
C07D 501/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15753924

PHARMACEUTICAL COMPOUND

IPC classification:
A61P 15/00, A61P 25/00, A61P 31/00, A61P 35/00, A61K 31/415, A61K 31/4164, A61K 31/4192, A61K 31/4196, A61K 31/42, A61K 31/433, A61K 31/44
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15836358

TETRAHYDRONAPHTHYRIDINE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/4375
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP17151348

ENGINEERED ANTI-IL-23 ANTIBODIES

IPC classification:
A61P 35/00, A61P 37/00, C07K 16/24, C12N 15/13, A61K 39/395
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
The application has been published
EP15831704

NOVEL CRYSTALLINE FORMS OF A BACE INHIBITOR, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 285/16
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15840606

S-IMINO-S-OXO IMINOTHIAZINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07C 309/14, C07C 335/32, C07D 295/088
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15837783

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15841974

DIAZINE-FUSED AMIDINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15843683

INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
C07D 498/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15844485

INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
A61K 31/4355
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15845304

INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
A61K 31/4704
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15843799

INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
A61K 31/4355
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15847644

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/444, A61K 31/506, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15847222

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/444, A61K 31/506, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15846420

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/444, A61K 31/506, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15846218

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/444, A61K 31/506, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15846682

C5-C6-FUSED TRICYCLIC IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 513/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15848373

SUBSTITUTED PYRIMIDINES AS INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
C07D 401/14, C07D 471/04, C07D 471/20
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15849713

SUBSTITUTED PYRIMIDINES AS INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
C07D 239/26
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15848319

SUBSTITUTED PYRIDINE INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
C07D 401/14, C07D 471/04, C07D 471/20
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15791278

INHIBITORS OF TRYPTOPHAN-2,3-DIOXYGENASE OR INDOLEAMINE-2,3-DIOXYGENASE

IPC classification:
A61P 15/18, A61P 25/28, A61P 31/04, A61P 35/00, A61K 31/472, A61K 31/4725, A61K 31/502
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15861650

AMINOPYRAZINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

IPC classification:
C07D 241/26, C07D 413/04, A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15864069

C5-C6-OXACYCLIC FUSED IMINOPYRIMIDINONE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15873902

SOLID DISPERSION FORMULATIONS OF ANTIVIRAL COMPOUNDS

IPC classification:
C07D 413/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15875975

BENZAMIDE IMIDAZOPYRAZINE BTK INHIBITORS

IPC classification:
C07D 471/04, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15875972

IMIDAZOPYRAZINE ANALOGS WITH 3-TERTIARY CARBON SUBSTITUTIONS AS BTK INHIBITORS

IPC classification:
A61K 31/44, A61K 31/4985, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15875971

BIARYLETHER IMIDAZOPYRAZINE BTK INHIBITORS

IPC classification:
C07D 487/04, A61K 31/5377, A61K 31/541, A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
Request for examination was made
EP15875974

TERTIARY ALCOHOL IMIDAZOPYRAZINE BTK INHIBITORS

IPC classification:
C07D 487/04, A61K 31/5377, A61K 31/541, A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
Request for examination was made
EP15875967

BTK INHIBITORS

IPC classification:
C07D 487/04, A61K 31/5377, A61K 31/541, A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
Request for examination was made
EP15875968

BTK INHIBITORS

IPC classification:
C07D 487/04, A61K 31/5377, A61K 31/541, A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
Request for examination was made
EP16747041

AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST

IPC classification:
C07D 239/84, C07D 403/12, A61K 31/517
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
Request for examination was made

Please Sign in to use this feature